Allosteric Regulation by Sodium of the Binding of [³H]Cocaine and [³H]GBR 12935 to Rat and Bovine Striata

References

• Albers R. W., Siegel G. J., Katzman R., Agranoff B. W. Basic Neurochemistry. Little, Brown and Co., Boston 1972; 692
   Google Scholar
• Andersen P. H. Biochemical and pharmacological characterization of ‘3H’GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J. Neurochem. 1987; 48: 1887–1896
   PubMed Web of Science ®Google Scholar
• Berger P., Elsworth J. D., Reith M. EA, Tanen D., Roth R. H. Complex interaction of cocaine with the dopamine uptake carrier. Eur. J. Pharmacol. 1990; 176: 251–252
   PubMed Web of Science ®Google Scholar
• Bogdanski D. F., Tissari A., Brodie B. B. Role of sodium, potassium, ouabain and reserpine in uptake, storage and metabolism of biogenic amines in synaptosomes. Life Sci. 1968; 7: 419–428
   PubMed Web of Science ®Google Scholar
• Boja J. W., Kuhar M. J. ‘3H’Cocaine binding and inhibition of ‘3H’dopamine uptake is similar in both the rat striatum and nucleus accumbens. Eur. J. Pharmacol. 1989; 173: 215–217
   PubMed Web of Science ®Google Scholar
• Brown P. A., Vernikos J. Antihistamine effect on synaptosomal uptake of serotonin, norepinephrine and dopamine. Eur. J. Pharmacol. 1980; 65: 89–92
   PubMed Web of Science ®Google Scholar
• Bürgisser E. Radioligand-receptor binding studies: what's wrong with the Scatchard analysis. Trend. Pharmacol. Sci. 1984; 5: 142–144
   Web of Science ®Google Scholar
• Bylund D. B. Graphic presentation and analysis of inhibition data from ligand-binding experiments. Analyt. Biochem. 1986; 159: 50–57
   PubMed Web of Science ®Google Scholar
• Calligaro D. O., Eldefrawi M. E. Central and peripheral cocaine receptors. J. Pharmacol. Exp. Therap. 1987; 243: 61–68
   PubMed Web of Science ®Google Scholar
• Calligaro D. O., Eldefrawi M. E. High affinity stereospecific binding of ‘3H’cocaine in striatum and its relationship to the dopamine transporter. Memb. Biochem. 1988; 7: 87–106
   Google Scholar
• Coyle J. T., Snyder S. H. Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science 1969; 166: 899–901
   PubMed Web of Science ®Google Scholar
• DeWit J., Wise R. A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide but not with the noradrenergic blockers phentolamine and phenoxybenzamine. Can. J. Psychol. 1977; 31: 195–203
   PubMed Web of Science ®Google Scholar
• Giros B., ElMestikawy S., Bertrand L., Caron M. G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS 1991; 295: 149–154
   PubMed Web of Science ®Google Scholar
• Goeders N. E., Smith J. E. Reinforcing properties of cocaine in the medial prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacol. Biochem. Behav. 1986; 25: 191–199
   PubMed Web of Science ®Google Scholar
• Grigoriadis D. E., Wilson ?, Low A. A., Sharkey J. S., Kuhar M. J. Dopamine transport sites selectively labeled by a novel photoaffinity probe: 125I DEEP. J. Neurosci. 1989; 8: 2660–2670
   Google Scholar
• Howell L. L., Byrd L. D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J. Pharmacol. Exp. Therap. 1991; 258: 178–185
   PubMed Web of Science ®Google Scholar
• Iversen L. L. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmacol. 1971; 41: 571–591
   PubMed Web of Science ®Google Scholar
• Janowsky A., Berger P., Vocci F., Labarca R., Skolnick P., Paul S. M. Characterization of sodium-dependent ‘3H’GBR-12935 binding in brain: a radioligand for selective labeling of the dopamine transport complex. J. Neurochem. 1986; 46: 1272–1276
   PubMed Web of Science ®Google Scholar
• Javitch J. A., Blaustein R. O., Snyder S. H. ‘3H’Mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Mol. Pharmacol. 1984; 26: 35–44
   PubMed Web of Science ®Google Scholar
• Kennedy L. T., Hanbauer I. Sodium-sensitive cocaine binding to rat striatal membranes: possible relationship to dopamine uptake sites. J. Neurochem. 1983; 41: 172–178
   PubMed Web of Science ®Google Scholar
• Kilty J. E., Lorang D., Amara S. G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991; 254: 578–579
   PubMed Web of Science ®Google Scholar
• Komiskey H. L., Miller D. D., LaPidus J. B., Patil P. N. The isomers of cocaine and tropacocaine: effect on 3H-catecholamine uptake by rat brain synaptosomes. Life Sci. 1977; 21: 1117–1122
   PubMed Web of Science ®Google Scholar
• Kuhar M. J., Ritz M. C., Boja J. W. The dopamine hypothesis of the reinforcing properties of cocaine. Trend. Neurolog. Sci. 1991; 14: 299–302
   PubMed Web of Science ®Google Scholar
• Lee C. M., Javitch J. A., Snyder S. H. Characterization of ‘3H’desipramine binding associated with neuronal norepinephrine uptake sites in rat brain membranes. J. Neurosci. 1982; 2: 1515–1525
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 256–275
   Web of Science ®Google Scholar
• Madras B. K., Fahey M. A., Bergman J., Canfield D. R., Spealman R. D. Effects of cocaine and related drugs in nonhuman primates. I. ‘3H’Cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Therap. 1989a; 251: 131–141
   PubMed Web of Science ®Google Scholar
• Madras B. K., Spealman R. D., Fahey M. A., Neumeyer J. L., Saha J. K., Milius R. A. Cocaine receptors labeled by ‘3H’2β-carbomethoxy-3-β-(4-fluorophenyl)tropane. Mol. Pharmacol. 1989b; 36: 518–524
   PubMed Web of Science ®Google Scholar
• Mayser W., Heinrich B., Schloss P. Isolation of cDNAs encoding a novel number of the neurotransmitter transporter gene family. FEBS 1991; 295: 203–206
   PubMed Web of Science ®Google Scholar
• Niznik H. B., Tyndale R. F., Sallee F. R., Gonzalez F. J., Hardwick J. P., Inaba T., Kalow W. The dopamine transporter and cytochrome P45011D1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct ‘3H’GBR-12935 binding proteins. Archiv. Biochem. Biophys. 1990; 276: 424–432
   PubMed Web of Science ®Google Scholar
• Pert C. B., Pasternak G., Snyder S. H. Opiate agonists and antagonists discriminated by receptor binding in brain. Science 1973; 182: 1359–1361
   PubMed Web of Science ®Google Scholar
• Pert C. B., Snyder S. H. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 1974; 10: 868–879
   Web of Science ®Google Scholar
• Reith M. EA, Meisler B. E., Sershen H., Lajtha A. ‘3H’Cocaine binding in brain is inhibited by Tris (hydroxymethyl)amino methane. J. Neurosci. Meth. 1984; 12: 151–154
   PubMed Web of Science ®Google Scholar
• Richelson E., Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 1984; 104: 277–286
   PubMed Web of Science ®Google Scholar
• Ritz M. C., Lamb R. J., Goldberg S. R., Kuhar M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219–1223
   PubMed Web of Science ®Google Scholar
• Roberts D. CS, Koob G. F., Klonoff P., Fibiger H. C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 1980; 12: 781–787
   PubMed Web of Science ®Google Scholar
• Sallee F. R., Fogel E. L., Schwartz E., Choi S. M., Cumin D. P., Niznik H. B. Photoaffinity labeling of the mammalian dopamine transporter. FEBS 1989; 26: 219–224
   Google Scholar
• Scheffel V., Boja J. W., Kuhar M. J. Cocaine receptors: in vivo labeling with 3H-(-)cocaine, 3H-WIN 35,065–2, and 3H-WIN 35,428. Synapse 1989; 4: 390–392
   PubMed Web of Science ®Google Scholar
• Schoemaker H., Nickolson V. J. Dopamine uptake by rat striatal synaptosomes: time-and temperature-dependent decay and protection by dithiothreitol and dopamine. J. Neurochem. 1983; 40: 922–928
   PubMed Web of Science ®Google Scholar
• Schoemaker H., Pimoule C., Arbilla S., Scatton B., Javoy-Agid F., Langer S. Z. Sodium dependent ‘3H’cocaine binding associated with dopanüne uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease. N-S Arch. Pharmacol. 1985; 329: 227–235
   PubMed Web of Science ®Google Scholar
• Sershen H., Reith M. EA, Hashim A., Lajtha A. Reduction of dopamine uptake and cocaine binding in mouse striatum by N -methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur. J. Pharmacol. 1984; 102: 175–178
   PubMed Web of Science ®Google Scholar
• Shimada S., Kitayama S., Lin C. L., Patel A., Nanthakumar E., Gregor P., Kuhar M., Uhl G. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 1991; 254: 576–578
   PubMed Web of Science ®Google Scholar
• Spealman R. D., Madras B. K., Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J. Pharmacol. Exp. Therap. 1989; 251: 142–149
   PubMed Web of Science ®Google Scholar
• Stockton J. M., Birdsall N. JM, Burgen A. SV, Hulme E. C. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 1983; 23: 551–557
   PubMed Web of Science ®Google Scholar
• White T. D., Keen P. The role of internal and external Na+ and K+ on the uptake of ‘3H’noradrenaline by synaptosomes prepared from rat brain. Biochim. Biophys. Acta 1970; 196: 285–295
   PubMed Web of Science ®Google Scholar
• White T. D., Paton D. M. Effects of external Na+ and K+ on the initial rats of noradrenaline uptake by synaptosomes prepared from rat brain. Biochim. Biophys. Acta 1972; 226: 116–127
   Google Scholar